Status:
COMPLETED
Determination of Risk Factors and Mortality for Pediatric Chronic Critical Illness in Turkey
Lead Sponsor:
Yuzuncu Yil University
Collaborating Sponsors:
Kahramanmaras Sutcu Imam University
Izmir Ataturk Training and Research Hospital
Conditions:
Critical Illness
Eligibility:
All Genders
Up to 18 years
Brief Summary
It is predicted that the number of Pediatric Chronic Critical Illness increases similar to adult all over the world. The prevalence of Pediatric Chronic Critical Illness in Turkey is unknown. The inve...
Detailed Description
Patients receiving acute critical cause of ICU in the Intensive Care Unit (ICU) may be hospitalized for longer periods of time due to accompanying diseases or iatrogenic causes. This disease is called...
Eligibility Criteria
Inclusion
- Chronic Critical IIlness
- The patients who are younger than 18 years old and staying in ICU for at least 14 days.
- (The patients who is newborn and stay in the intensive care unit for 30 days in addition to prematurity).
- At least one of the additional criteria;
- Prolonged acute mechanical ventilation
- Tracheostomy
- Sepsis
- Severe wound (burn) or trauma
- Encephalopathy (Post resuscitation syndrome, Asphyxia, Intra-cranial hemorrhage, Metabolic disease, etc.)
- Traumatic brain injury
- Status epilepticus
- Post operative (Cardiac and noncardiac)
- Neuromuscular disease (Spinal Muscular Dystrophy, Cerebral Palsy, Muscular Dystrophy)
Exclusion
- Patients with a disease other than a chronic critical disease
- Patients older than 18 years
Key Trial Info
Start Date :
November 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2018
Estimated Enrollment :
888 Patients enrolled
Trial Details
Trial ID
NCT03308513
Start Date
November 1 2017
End Date
October 31 2018
Last Update
September 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yuzuncu Yil University, School of Medicine
Van, Tusba / Zeve Kampus, Turkey (Türkiye), 65080